organic compounds
Methyl 5-chloro-2-nitrobenzoate
aTianjin University of Commerce, Tianjin 300134, People's Republic of China, and bTianjin Institute of Pharmaceutical Research, Tianjin, 300193, People's Republic of China
*Correspondence e-mail: lyshu@tjcu.edu.cn
In the title compound, C8H6ClNO4, the nitro and acetoxy groups attached to the benzene ring at neighbouring positions are twisted from its plane by 29.4 (1) and 49.7 (1)°, respectively. In the crystal, weak C—H⋯O hydrogen bonds link molecules into layers parallel to (101). The crystal packing exhibits short intermolecular C⋯O distances of 2.925 (3) Å.
Related literature
The title compound is an intermediate of the oral vasopressin V2-receptor antagonist tolvaptan. For applications of tolvaptan, see: Nemerovski & Hutchinson (2010). For the synthesis of the title compound, see: Kondo et al. (1999). For a related structure, see: Liu et al. (2008).
Experimental
Crystal data
|
Refinement
|
Data collection: CrystalClear (Rigaku/MSC, 2005); cell CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.
Supporting information
https://doi.org/10.1107/S1600536811044072/cv5162sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536811044072/cv5162Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536811044072/cv5162Isup3.cdx
Supporting information file. DOI: https://doi.org/10.1107/S1600536811044072/cv5162Isup4.cml
To a stirred solution of the 5-chloro-2-nitrobenzoic acid (10 g, 50 mmol) in acetone(60 ml) was added K2CO3 (10.3 g, 74 mmol) and Me2SO4 (6.2 ml, 64.7 mmol). The mixture was heated at reflux for 30 min. The reaction mixture was then poured into an ice-water bath and extracted with ethyl acetate. The organic layer was separated and dried over MgSO4. then the filtrate was concentrate under reduced pressure to afford the methyl ester as a white solid. Pure compound (I) was obstained by crystallizing from methanol. Crystals of (I) suitable for X-ray diffraction were obstained by slow evaporation of an methanol solution.
All H atoms were positioned geometrically and refined using a riding model, with d(C—H) = 0.95 - 0.99 Å, and Uiso(H) = 1.2 or 1.5 Ueq.
Tolvaptan is an oral nonpeptide selective vasopressin V2-receptor antagonist indicated for the treatment of clinically relevant hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or syndrome of inappropriate antidiuretic hormone (Nemerovski et al., 2010). Now, we present the
of the title compound (I) (Kondo et al., 1999), an intermediate of Tolvaptan.In (I) (Fig. 1), all bond lengths and angles are normal and correspond to those observed in the analougs (Liu et al., 2008). The acetoxy and nitro groups attached to the benzene ring at neighbouring positions are twisted from its plane at 49.7 (1) and 29.4 (1)°, respectively. In the
weak C—H···O interactions (Table 1) link molecules into layers parallel to (101) plane. Short intermolecular C···O distances of 2.925 (3) Å observed in the structure.The title compound is an intermediate of the oral vasopressin V2-receptor antagonist tolvaptan. For applications of tolvaptan, see: Nemerovski & Hutchinson (2010). For the synthesis of the title compound, see: Kondo et al. (1999). For a related structure, see: Liu et al. (2008).
Data collection: CrystalClear (Rigaku/MSC, 2005); cell
CrystalClear (Rigaku/MSC, 2005); data reduction: CrystalClear (Rigaku/MSC, 2005); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).Fig. 1. The molecular structure of (I), with the atom-numbering scheme and 50% probability displacement ellipsoids. |
C8H6ClNO4 | F(000) = 440 |
Mr = 215.59 | Dx = 1.593 Mg m−3 |
Monoclinic, P21/n | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -P 2yn | Cell parameters from 2662 reflections |
a = 4.2616 (9) Å | θ = 1.8–27.5° |
b = 22.470 (5) Å | µ = 0.41 mm−1 |
c = 9.3894 (19) Å | T = 113 K |
β = 90.64 (3)° | Prism, colorless |
V = 899.1 (3) Å3 | 0.16 × 0.14 × 0.12 mm |
Z = 4 |
Rigaku Saturn diffractometer | 1564 independent reflections |
Radiation source: rotating anode | 1400 reflections with I > 2σ(I) |
Confocal monochromator | Rint = 0.031 |
ω scans | θmax = 25.0°, θmin = 2.4° |
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005) | h = −4→5 |
Tmin = 0.937, Tmax = 0.952 | k = −26→20 |
5007 measured reflections | l = −11→11 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.041 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.116 | H-atom parameters constrained |
S = 1.07 | w = 1/[σ2(Fo2) + (0.0708P)2 + 0.3934P] where P = (Fo2 + 2Fc2)/3 |
1564 reflections | (Δ/σ)max = 0.001 |
128 parameters | Δρmax = 0.27 e Å−3 |
0 restraints | Δρmin = −0.27 e Å−3 |
C8H6ClNO4 | V = 899.1 (3) Å3 |
Mr = 215.59 | Z = 4 |
Monoclinic, P21/n | Mo Kα radiation |
a = 4.2616 (9) Å | µ = 0.41 mm−1 |
b = 22.470 (5) Å | T = 113 K |
c = 9.3894 (19) Å | 0.16 × 0.14 × 0.12 mm |
β = 90.64 (3)° |
Rigaku Saturn diffractometer | 1564 independent reflections |
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005) | 1400 reflections with I > 2σ(I) |
Tmin = 0.937, Tmax = 0.952 | Rint = 0.031 |
5007 measured reflections |
R[F2 > 2σ(F2)] = 0.041 | 0 restraints |
wR(F2) = 0.116 | H-atom parameters constrained |
S = 1.07 | Δρmax = 0.27 e Å−3 |
1564 reflections | Δρmin = −0.27 e Å−3 |
128 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.83432 (12) | 0.09111 (2) | 1.09984 (5) | 0.0272 (2) | |
O1 | 0.1416 (4) | 0.05968 (8) | 0.42100 (17) | 0.0423 (5) | |
O2 | −0.1876 (4) | 0.12282 (9) | 0.48951 (17) | 0.0409 (5) | |
O3 | 0.1575 (4) | 0.22747 (7) | 0.57507 (16) | 0.0364 (4) | |
O4 | −0.0357 (3) | 0.22861 (6) | 0.78230 (15) | 0.0263 (4) | |
N1 | 0.0553 (5) | 0.09256 (8) | 0.51178 (19) | 0.0282 (5) | |
C1 | 0.2555 (5) | 0.09452 (9) | 0.6557 (2) | 0.0224 (5) | |
C2 | 0.4194 (5) | 0.04329 (9) | 0.7038 (2) | 0.0273 (5) | |
H2 | 0.4148 | 0.0092 | 0.6478 | 0.033* | |
C3 | 0.6002 (5) | 0.04214 (9) | 0.8420 (2) | 0.0263 (5) | |
H3 | 0.7041 | 0.0077 | 0.8707 | 0.032* | |
C4 | 0.6111 (5) | 0.09270 (8) | 0.9265 (2) | 0.0215 (5) | |
C5 | 0.4463 (5) | 0.14420 (9) | 0.8781 (2) | 0.0224 (5) | |
H5 | 0.4519 | 0.1783 | 0.9342 | 0.027* | |
C6 | 0.2642 (5) | 0.14566 (9) | 0.7406 (2) | 0.0218 (5) | |
C7 | 0.1199 (5) | 0.20438 (9) | 0.6857 (2) | 0.0228 (5) | |
C8 | −0.1662 (6) | 0.28749 (10) | 0.7466 (2) | 0.0323 (5) | |
H8A | 0.0017 | 0.3157 | 0.7373 | 0.049* | |
H8B | −0.3039 | 0.3001 | 0.8209 | 0.049* | |
H8C | −0.2814 | 0.2850 | 0.6584 | 0.049* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0369 (4) | 0.0243 (3) | 0.0204 (3) | 0.0011 (2) | −0.0024 (2) | 0.00056 (18) |
O1 | 0.0641 (13) | 0.0388 (10) | 0.0241 (9) | 0.0017 (8) | 0.0011 (8) | −0.0105 (7) |
O2 | 0.0322 (10) | 0.0596 (12) | 0.0308 (9) | 0.0044 (8) | 0.0003 (7) | 0.0013 (8) |
O3 | 0.0481 (10) | 0.0359 (9) | 0.0256 (9) | 0.0124 (7) | 0.0201 (7) | 0.0125 (7) |
O4 | 0.0334 (9) | 0.0244 (8) | 0.0215 (8) | 0.0032 (6) | 0.0139 (6) | 0.0031 (6) |
N1 | 0.0335 (11) | 0.0305 (10) | 0.0206 (10) | −0.0064 (8) | 0.0023 (8) | 0.0002 (8) |
C1 | 0.0231 (11) | 0.0270 (11) | 0.0174 (11) | −0.0047 (8) | 0.0048 (8) | −0.0011 (8) |
C2 | 0.0352 (12) | 0.0223 (10) | 0.0246 (11) | −0.0058 (9) | 0.0087 (9) | −0.0063 (8) |
C3 | 0.0331 (12) | 0.0209 (10) | 0.0252 (12) | −0.0008 (9) | 0.0071 (9) | 0.0024 (8) |
C4 | 0.0255 (11) | 0.0217 (10) | 0.0176 (10) | −0.0033 (8) | 0.0055 (8) | 0.0018 (8) |
C5 | 0.0280 (11) | 0.0215 (10) | 0.0178 (10) | −0.0035 (8) | 0.0100 (8) | −0.0003 (8) |
C6 | 0.0229 (11) | 0.0252 (10) | 0.0175 (10) | −0.0030 (8) | 0.0099 (8) | 0.0020 (8) |
C7 | 0.0242 (10) | 0.0258 (10) | 0.0186 (11) | −0.0017 (8) | 0.0049 (8) | −0.0004 (8) |
C8 | 0.0416 (14) | 0.0250 (11) | 0.0307 (13) | 0.0076 (10) | 0.0123 (10) | 0.0038 (9) |
Cl1—C4 | 1.876 (2) | C2—H2 | 0.9300 |
O1—N1 | 1.189 (2) | C3—C4 | 1.386 (3) |
O2—N1 | 1.254 (3) | C3—H3 | 0.9300 |
O3—C7 | 1.174 (2) | C4—C5 | 1.425 (3) |
O4—C7 | 1.254 (2) | C5—C6 | 1.500 (3) |
O4—C8 | 1.472 (3) | C5—H5 | 0.9300 |
N1—C1 | 1.590 (3) | C6—C7 | 1.542 (3) |
C1—C6 | 1.399 (3) | C8—H8A | 0.9600 |
C1—C2 | 1.418 (3) | C8—H8B | 0.9600 |
C2—C3 | 1.502 (3) | C8—H8C | 0.9600 |
C7—O4—C8 | 115.29 (16) | C4—C5—C6 | 122.73 (18) |
O1—N1—O2 | 118.6 (2) | C4—C5—H5 | 118.6 |
O1—N1—C1 | 117.30 (18) | C6—C5—H5 | 118.6 |
O2—N1—C1 | 124.10 (17) | C1—C6—C5 | 118.89 (18) |
C6—C1—C2 | 118.4 (2) | C1—C6—C7 | 120.30 (18) |
C6—C1—N1 | 121.16 (18) | C5—C6—C7 | 120.47 (17) |
C2—C1—N1 | 120.40 (17) | O3—C7—O4 | 121.8 (2) |
C1—C2—C3 | 122.38 (18) | O3—C7—C6 | 128.04 (18) |
C1—C2—H2 | 118.8 | O4—C7—C6 | 110.01 (16) |
C3—C2—H2 | 118.8 | O4—C8—H8A | 109.5 |
C4—C3—C2 | 119.62 (19) | O4—C8—H8B | 109.5 |
C4—C3—H3 | 120.2 | H8A—C8—H8B | 109.5 |
C2—C3—H3 | 120.2 | O4—C8—H8C | 109.5 |
C3—C4—C5 | 118.0 (2) | H8A—C8—H8C | 109.5 |
C3—C4—Cl1 | 119.63 (16) | H8B—C8—H8C | 109.5 |
C5—C4—Cl1 | 122.36 (15) | ||
O1—N1—C1—C6 | 152.58 (19) | N1—C1—C6—C5 | 177.54 (15) |
O2—N1—C1—C6 | −28.3 (3) | C2—C1—C6—C7 | 173.45 (17) |
O1—N1—C1—C2 | −30.1 (3) | N1—C1—C6—C7 | −9.2 (3) |
O2—N1—C1—C2 | 149.0 (2) | C4—C5—C6—C1 | −0.1 (3) |
C6—C1—C2—C3 | 0.1 (3) | C4—C5—C6—C7 | −173.43 (18) |
N1—C1—C2—C3 | −177.31 (16) | C8—O4—C7—O3 | 0.0 (3) |
C1—C2—C3—C4 | −0.4 (3) | C8—O4—C7—C6 | 175.57 (17) |
C2—C3—C4—C5 | 0.4 (3) | C1—C6—C7—O3 | −48.6 (3) |
C2—C3—C4—Cl1 | 179.53 (14) | C5—C6—C7—O3 | 124.6 (2) |
C3—C4—C5—C6 | −0.1 (3) | C1—C6—C7—O4 | 136.20 (19) |
Cl1—C4—C5—C6 | −179.27 (14) | C5—C6—C7—O4 | −50.6 (2) |
C2—C1—C6—C5 | 0.2 (3) |
D—H···A | D—H | H···A | D···A | D—H···A |
C2—H2···O1i | 0.93 | 2.53 | 3.206 (3) | 130 |
C8—H8B···O3ii | 0.96 | 2.47 | 3.200 (3) | 132 |
Symmetry codes: (i) −x+1, −y, −z+1; (ii) x−1/2, −y+1/2, z+1/2. |
Experimental details
Crystal data | |
Chemical formula | C8H6ClNO4 |
Mr | 215.59 |
Crystal system, space group | Monoclinic, P21/n |
Temperature (K) | 113 |
a, b, c (Å) | 4.2616 (9), 22.470 (5), 9.3894 (19) |
β (°) | 90.64 (3) |
V (Å3) | 899.1 (3) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.41 |
Crystal size (mm) | 0.16 × 0.14 × 0.12 |
Data collection | |
Diffractometer | Rigaku Saturn |
Absorption correction | Multi-scan (CrystalClear; Rigaku/MSC, 2005) |
Tmin, Tmax | 0.937, 0.952 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 5007, 1564, 1400 |
Rint | 0.031 |
(sin θ/λ)max (Å−1) | 0.595 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.041, 0.116, 1.07 |
No. of reflections | 1564 |
No. of parameters | 128 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.27, −0.27 |
Computer programs: CrystalClear (Rigaku/MSC, 2005), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008), SHELXTL (Sheldrick, 2008).
D—H···A | D—H | H···A | D···A | D—H···A |
C2—H2···O1i | 0.93 | 2.53 | 3.206 (3) | 129.6 |
C8—H8B···O3ii | 0.96 | 2.47 | 3.200 (3) | 132.4 |
Symmetry codes: (i) −x+1, −y, −z+1; (ii) x−1/2, −y+1/2, z+1/2. |
Acknowledgements
The authors thank Mr Hai-Bin Song of Nankai University for his kind assistance with the X-ray
and for helpful suggestions.References
Kondo, K., Ogawa, H., Yamashita, H. & Miyamoto, H. (1999). Bioorg. Med. Chem. 7, 1743–1754. Web of Science CrossRef PubMed CAS Google Scholar
Liu, B.-N., Tang, S.-G., Li, H.-Y., Xu, Y.-M. & Guo, C. (2008). Acta Cryst. E64, o456. Web of Science CSD CrossRef IUCr Journals Google Scholar
Nemerovski, C. & Hutchinson, D. J. (2010). Clin. Ther. 32, 1015–1032. Web of Science CrossRef CAS PubMed Google Scholar
Rigaku/MSC (2005). CrystalClear. Rigaku/MSC Inc., The Woodlands, Texas, USA. Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Tolvaptan is an oral nonpeptide selective vasopressin V2-receptor antagonist indicated for the treatment of clinically relevant hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or syndrome of inappropriate antidiuretic hormone (Nemerovski et al., 2010). Now, we present the crystal structure of the title compound (I) (Kondo et al., 1999), an intermediate of Tolvaptan.
In (I) (Fig. 1), all bond lengths and angles are normal and correspond to those observed in the analougs (Liu et al., 2008). The acetoxy and nitro groups attached to the benzene ring at neighbouring positions are twisted from its plane at 49.7 (1) and 29.4 (1)°, respectively. In the crystal structure, weak C—H···O interactions (Table 1) link molecules into layers parallel to (101) plane. Short intermolecular C···O distances of 2.925 (3) Å observed in the structure.